Aug 13, 2023, 08:56
Stephen V Liu: More data showing the importance of *waiting* for NGS results before starting non–small-cell lung cancer therapy whenever possible!
As per Stephen V. Liu, the Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, in a tweet, he mentions that the “More data showing the importance of *waiting* for NGS results before starting non–small-cell lung cancer therapy whenever possible!
Retrospective analysis JCO Oncology Practice show that when treatment of driver+ non–small-cell lung cancer before biomarker results is associated with inferior survival.”
For article click here
Source: Stephen V Liu / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43